title: [Drugs in the coronary group (author's transl)].
abstract: The indication for either digitalis or exercise-therapy has to be reevaluated continuously. Reserpine enhances the toxic effect of digitalis. Beta-receptorblockers and nitrates complement each other and should be administrated on a large scale (supplemented prophylactically by nitrocompounds before exercise). The monotherapy aimed at should be initiated with a beta-receptorblocker in patients up to 50 years of age. Diuretics are the second type of drugs. Exercise therapy is contraindicated absolutely in cases of complex ventricular extrasystoles and relatively contraindicated for simple ventricular extrasystoles.
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D003327:Coronary Disease / Q000188:drug therapy*; D004071:Digitalis Glycosides / Q000627:therapeutic use*; D004232:Diuretics / Q000627:therapeutic use*; D005081:Exercise Therapy; D006801:Humans; D008875:Middle Aged; D009566:Nitrates / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D004071:Digitalis Glycosides; D004232:Diuretics; D009566:Nitrates; D012110:Reserpine
vernacular_title: Medikamente in der Koronargruppe.